ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676353; 2) Community: the network communities that were significantly associated with the response to NSC 676353; 3) Molecule: the relationships between components within communities and NSC 676353; 4) MDR: the compounds that were significantly associated with the NSC 676353.

NSC Compound Enrichment Correlation
NSC 670788 Null 0.0222343516878698 0.21903229
NSC 673796 9-Acridinamine, 7-methoxy-N-[2-[[2-(dimethylamino)ethyl]amino]ethyl]- 1-nitro- 0.0222343516878698 -0.0507672
NSC 176503 Fastigilin B 0.0244632509325736 0.18607305
NSC 180973 Tamoxifen citrate 0.0244632509325736 0.10478613
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0244632509325736 0.15564461
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0244632509325736 0.3004748
NSC 266491 Psorspermin 0.0244632509325736 0.14222485
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0244632509325736 0.27114266
NSC 282752 Eunicin 0.0244632509325736 0.18867095
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0244632509325736 -0.073832071
Total:93  Current:50    [First] [Prev] [Next] [Last]